Editor,

The 'red flag referral' system is currently under stress due to the huge number of suspected cancer referrals. There are guidelines from both the Northern Ireland Cancer Network (NICaN)[@b1] and the National Institute of Clinical Excellence (NICE)[@b2] regarding specific criteria for what constituents a red flag referral.

The red flag referral pathway is centred on two groups of patients:

1.  95% of patients identified with cancer should begin their definitive treatment within 62 days of referral (typically General Practice referrals)

2.  'In-hospital' referrals should begin definitive treatment within 31 days of consulting with a specialist and a treatment plan initiated

All upper and lower GI suspected cancer referrals were assessed over a 1-year period (October 2015 -- September 2016) in a district general hospital. Both 62- and 31-day referral pathways were analysed. Data were obtained from cancer trackers and checked for accuracy.

For suspected upper GI cancers, there were 2629 referrals over the 1-year period, divided into 1520 62-day referrals and 1109 31-day referrals. There were 164 (6.24%) confirmed cancers. 57 (3.75%) of these cancers were 62-day referrals and 107 (9.64%) cancers were 31-day.

There were 3951 referrals for suspected lower GI cancers over the 1-year period, with 2652 62-day referrals and 1299 31-day referrals. There were 188 (4.76%) confirmed cancers. 63 (2.38%) of these cancers were 62-day referrals and 125 (9.62%) cancers were 31-day.

There was very low progression from suspected to confirmed cancer from red flag referrals for both upper and lower GI symptoms. 62-day referrals for suspected cancer were particularly low (3.75% and 2.38% for upper and lower GI referrals respectively).

In the current environment of increasing demands on the NHS -- is it time for current red flag referral criteria to be revisited? We should have a true partnership between secondary care and general practice - setting up a working group between general surgeons, gastroenterologists, and general practitioners to revisit guidelines to determine what is realistic and deliverable in the current financial constrained environment. Perhaps such 'red flag' patients should be referred to community assessment centres for direct access endoscopy. These trained endoscopists may be nurses, associate specialists, or staff grade doctors. It would be especially important for a number of these endoscopists to be sessional family doctors, who are JAG (Joint Advisory Group in Endoscopy) accredited. This would encourage collaboration between general practice and secondary care, allowing for validation and audit of the red flag referral pathway.

UMJ is an open access publication of the Ulster Medical Society (<http://www.ums.ac.uk>).
